The Italian breakthrough in CRISPR trials for rare diseases: a focus on beta-thalassemia and sickle cell disease treatment
Can Lupus Trigger The Onset Of Bipolar Disorder?
Lupus can cause neuropsychiatric symptoms, such as sudden mood changes or psychosis, which may resemble bipolar disorder.
Lupus can sometimes mimic bipolar disorder, especially when neuropsychiatric symptoms like mood changes, mania, or psychosis are involved.
These symptoms may stem from neuropsychiatric lupus (NPSLE) or be side effects of certain lupus medications.
Additionally, some bipolar medications may trigger lupus-like symptoms, which adds another layer of complexity.
Before looking closer at the links between lupus and bipolar disorder, it's worth considering the symptoms of each condition and where they may overlap.
Lupus symptoms
Bipolar disorder symptoms
Overlapping symptoms
Systemic lupus erythematosus (SLE) isn't considered a direct cause of bipolar disorder (BD). However, there may be a link between the two conditions.
In a large 2017 study comparing 5,018 participants with SLE to 25,090 participants without SLE (controls), bipolar disorder was found in 0.62% of SLE patients versus 0.26% in controls — a statistically meaningful difference.
The study also noted that smoking was more common in people with bipolar disorder, and both SLE and smoking were linked to an increased risk of bipolar disorder. This suggests that the autoimmune processes in SLE, which can affect the central nervous system, may contribute to symptoms similar to those in bipolar disorder.
Can lupus mimic bipolar disorder?
SLE can present with neuropsychiatric symptoms, known as neuropsychiatric lupus (NPSLE). This may mimic bipolar disorder and lead to potential misdiagnosis.
It's estimated that two-thirds of individuals with SLE experience neuropsychiatric symptoms, such as mania and psychosis.
In fact, studies show that depression affects up to 39%, and cognitive dysfunction affects as many as 80% of people with SLE. A person's emotional response to their illness can lead to anxiety in about 24% of cases. Current biomarkers used to assess neuropsychiatric issues in SLE are linked to inflammation and other problems in the brain.
A case study highlights this issue: A 26-year-old woman was initially diagnosed with bipolar disorder due to severe behavioral changes, including irritability and mood changes over 4 years. However, she became unconscious and was found to have SLE and limbic encephalitis, which affects the brain's emotional centers.
An MRI revealed damage in the pons and atrophy in the claustrum and temporal lobe, indicating ongoing brain involvement. The woman exhibited significant neurological problems, including confusion and unusual movements.
An older 2009 study discusses a 15-year-old girl with a family history of bipolar disorder and schizophrenia who exhibited symptoms of an affective disorder. Initially diagnosed with bipolar disorder with catatonic features, she required multiple hospitalizations for mood disturbances.
Two years later, she developed a malar rash, leading to a rheumatologic evaluation that identified cerebral vasculitis. She was diagnosed with NPSLE and responded well to steroid treatment, allowing her to discontinue psychiatric medications.
Drug-induced lupus (DIL) affects an estimated 15,000 to 30,000 people in the United States each year. This temporary condition causes lupus-like symptoms and is triggered by certain medications.
Since 1945, over 90 drugs have been linked to DIL. Some of these are used to treat bipolar disorder:
Other mood stabilizers and anticonvulsants may have a lower risk of inducing DIL, but it's wise for sensitive individuals to monitor for symptoms.
Can lupus medications cause bipolar symptoms?
Lupus medications don't cause bipolar disorder directly, but some may cause mood changes or psychiatric side effects that can resemble symptoms of bipolar disorder. These may include medications such as:
A case study highlighted a male patient with SLE who experienced a worsening of bipolar symptoms after taking chloroquine. Initially, he showed no psychiatric symptoms while on the medication, but subsequent use triggered severe depressive episodes and psychotic features.
Treating bipolar disorder and lupus together involves a careful, collaborative approach by healthcare professionals, as certain medications for one condition may impact the other.
Here's how they're typically managed together:
Medications
Mood stabilizers and antipsychotics (like lithium or quetiapine) are often used to manage bipolar symptoms. However, some bipolar medications, such as lamotrigine, have been linked to rare cases of drug-induced lupus, so they're used with caution.
Steroids (like prednisone) and immunosuppressants (such as mycophenolate mofetil) are common for lupus to reduce inflammation. However, steroids can affect mood, potentially triggering mania or depression in people with bipolar.
Doctors may opt for the lowest effective dose or consider steroid-sparing alternatives if mood instability is a concern.
Therapy and counseling
Psychotherapy, including cognitive behavioral therapy (CBT), can be valuable for managing mood changes, reducing stress, and building coping skills for those living with chronic illnesses like lupus or bipolar disorder.
Is There A Link Between Lupus And Tonsil Stones?
While there's no established link between lupus and tonsil stones, the inflammation associated with lupus may contribute to their formation.
Tonsil stones, or tonsilloliths, aren't specific to lupus. However, people with lupus may be at a higher risk due to the chronic inflammation and immune system dysregulation associated with the disease.
Lupus can also lead to swelling in the tonsils and throat, which can result in dry mouth and a greater accumulation of bacteria and debris.
This environment may promote tonsil stone formation, especially in those who experience recurrent throat infections or have other autoimmune conditions affecting oral health.
Tonsil stones form when debris — such as food particles, dead cells, and bacteria — accumulates in the crevices of the tonsils.
Over time, this debris can harden or calcify, leading to the formation of small, often foul-smelling stones.
Contributing factors include:
Lupus can indirectly contribute to the development of tonsil stones through several mechanisms:
The tonsils play a key role in your immune system. Researchers in Sweden looked at data from 179,875 people who had a tonsillectomy between 1997 and 2012 and tracked them for the development of autoimmune diseases.
They found that 5,357 of these individuals were later diagnosed with autoimmune diseases, which is about 1.34 times more than what would be expected in the general population.
Achieving Low Disease Activity In Lupus Reduces Organ Damage And Flare Risk
A multinational study offers new hope for patients with systemic lupus erythematosus (SLE) and high disease activity, showing that achieving low disease activity or remission can significantly reduce the risk of organ damage and disease flare.
The study, led by Rangi Kandane-Rathnayake and colleagues, analysed data from 1,029 SLE patients with high disease activity status (HDAS), defined as a SLEDAI-2K score of 10 or higher. The research examined the frequency of attaining the lupus low disease activity state (LLDAS) or remission (REM) and their impact on patient outcomes.
The findings were encouraging: 71% of patients achieved LLDAS at least once during the study period, while 41% achieved remission. Even short periods of low disease activity were associated with a reduced risk of organ damage and flare, underscoring the value of pursuing these treatment goals. Sustained LLDAS or remission provided even greater protection but was more challenging to maintain. Only 37% of patients achieved at least three months of sustained LLDAS, and the proportions dwindled for longer durations.
"Achieving and maintaining low disease activity or remission in lupus patients with high disease activity is a critical step in reducing long-term complications," the researchers noted. "While challenging, these targets provide significant protection against damage and flare, making them valuable benchmarks in patient care."
The study highlights the importance of personalised treatment strategies that aim to achieve low disease activity as a practical goal, particularly in patients with high disease activity. It also emphasises the need for continued efforts to develop therapies that enable sustained remission or low disease activity over longer periods.
Aleksandra Zurowska, EMJ
Reference
Kandane-Rathnayake R et al. Association of Lupus Low Disease Activity State And Remission With Reduced Organ Damage And Flare in Systemic lupus erythematosus Patients With High Disease Activity. Rheumatology. 2024;DOI: https://doi.Org/10.1093/rheumatology/keae631.
Comments
Post a Comment